跳至主要内容
临床试验/NCT02439502
NCT02439502已完成4 期

Single Center, Prospective, Open Label Post Marketing Study of EndoChoice's Fuse® Endoscopic System Performance In Routine Practice

EndoChoice Innovation Center, Ltd.0 个研究点目标入组 29 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
29
主要终点
Number of findings (abnormal GI findings, such as polyps and tec.) per diagnostic procedure, using Fuse® system

研究概览

简要总结

The intent of this study is to evaluate the performance and usability of Fuse in routine practice. The participants are indicated for upper (gastroscopy) and lower (colonoscopy) gastrointestinal endoscopy procedures. The study is open label, prospective and Post Marketing study.

详细描述

The intent of this study is to evaluate the performance and usability of Fuse in routine practice EndoChoice's Fuse system - Fuse is an FDA, CE and AMAR approved Endoscopic system (Gastroscope and Colonoscope).

Fuse® system The Fuse system is intended for diagnostic visualization of the digestive tract. The system also provides access for therapeutic interventions using standard endoscopy tools. The Fuse system consists of camera heads, endoscopes, video system, light source and other ancillary equipment.

Fuse Colonoscopes in conjunction with the FuseBox™ processor are indicated for use within the lower digestive tract (including the anus, rectum, sigmoid colon, colon and ileocecal valve) for adult subjects.

Fuse Gastroscopes in conjunction with the FuseBox™ processor are indicated for use within the upper digestive tract (including the esophagus, stomach, and duodenum).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects ages 18 at least
  • The subject has been scheduled for routine screening upper or lower endoscopy, diagnostic work up, or endoscopic surveillance.
  • Signed informed consent

排除标准

  • Subjects who are currently enrolled in another clinical study

结局指标

主要结局

Number of findings (abnormal GI findings, such as polyps and tec.) per diagnostic procedure, using Fuse® system

时间窗: 1 outpatient hospitalization day for subject

次要结局

未报告次要终点

研究者

发起方
EndoChoice Innovation Center, Ltd.
申办方类型
Industry
责任方
Sponsor

相似试验